Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Schott, MD
University of Michigan
Principal Investigator - Giraldo Kato, MD
Pinnacle Oncology Hematology
Principal Investigator - Lori Goldstein, MD
Fox Chase Cancer Center
Principal Investigator - Raymond Perez, MD
University of Kansas Medical Center
Principal Investigator - Tiffany Avery, MD
Thomas Jefferson University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pinnacle Oncology Hematology; 9055 East del Camino
Scottsdale, Arizona, United States
- University of Kansas Medical Center; 4350 Shawnee Mission Parkway
Fairway, Kansas, United States
- University of Michigan; 1500 East Medical Center Drive
Ann Arbor, Michigan, United States
- Fox Chase Cancer Center; 333 Cottman Avenue
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital; 1025 Walnut Street
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Feb 2012
- Primary completion
- 25 Jun 2014
- Completion
- 15 Jan 2015
- Last update posted
- 27 Sept 2021
- Registered enrollment
- 33
- Registry id
- NCT02001974
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.